Works matching IS 00071188 AND DT 2013 AND VI 169 AND IP 2

Results: 26

Sulforaphane protects against ethanol-induced oxidative stress and apoptosis in neural crest cells by the induction of Nrf2-mediated antioxidant response.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 437, doi. 10.1111/bph.12133

By:

Chen, X;
Liu, J;
Chen, S‐Y

Publication type:

Article

Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 247, doi. 10.1111/j.1476-5381.2012.01965.x

By:

Jadczyk, T;
Faulkner, A;
Madeddu, P

Publication type:

Article

The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 304, doi. 10.1111/j.1476-5381.2012.02118.x

By:

Khan, Jaffar M;
Lyon, Alexander R;
Harding, Sian E

Publication type:

Article

Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.

Published in:

2013

By:

Varagic, Zdravko;
Ramerstorfer, Joachim;
Huang, Shengming;
Rallapalli, Sundari;
Sarto-Jackson, Isabella;
Cook, James;
Sieghart, Werner;
Ernst, Margot

Publication type:

journal article

Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interface.

Published in:

2013

By:

Varagic, Zdravko;
Wimmer, Laurin;
Schnürch, Michael;
Mihovilovic, Marko D;
Huang, Shengming;
Rallapalli, Sundari;
Cook, James M;
Mirheydari, Pantea;
Ecker, Gerhard F;
Sieghart, Werner;
Ernst, Margot

Publication type:

journal article

Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.

Published in:

2013

By:

González-Corrochano, R;
La Fuente, Jm;
Cuevas, P;
Fernández, A;
Chen, Mx;
Sáenz de Tejada, I;
Angulo, J

Publication type:

journal article

Different β-adrenoceptor subtypes coupling to cAMP or NO/cGMP pathways: implications in the relaxant response of rat conductance and resistance vessels.

Published in:

2013

By:

Flacco, N;
Segura, V;
Perez-Aso, M;
Estrada, S;
Seller, Jf;
Jiménez-Altayó, F;
Noguera, Ma;
D'Ocon, P;
Vila, E;
Ivorra, Md;
Seller, J F;
Noguera, M A;
Ivorra, M D

Publication type:

journal article

The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration.

Published in:

2013

By:

Eans, Shainnel O;
Ganno, Michelle L;
Reilley, Kate J;
Patkar, Kshitij A;
Senadheera, Sanjeewa N;
Aldrich, Jane V;
McLaughlin, Jay P

Publication type:

journal article

IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B1 and B2 receptors through a STAT6-dependent mechanism.

Published in:

2013

By:

Souza, Ppc;
Brechter, Ab;
Reis, Ri;
Costa, Cas;
Lundberg, P;
Lerner, Uh;
Souza, P P C;
Brechter, A B;
Reis, R I;
Costa, C A S;
Lerner, U H

Publication type:

journal article

Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor.

Published in:

2013

By:

Schrage, R;
Seemann, Wk;
Klöckner, J;
Dallanoce, C;
Racké, K;
Kostenis, E;
De Amici, M;
Holzgrabe, U;
Mohr, K;
Seemann, W K

Publication type:

journal article

Chemical genetics and its potential in cardiac stem cell therapy.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 318, doi. 10.1111/j.1476-5381.2012.01928.x

By:

Vieira, Joaquim M;
Riley, Paul R

Publication type:

Article

Issue Information.

Published in:: British Journal of Pharmacology, 2013, v. 169, n. 2, p. i, doi. 10.1111/j.1476-5381.2013.02157.x
Publication type:: Article

Supra-physiological efficacy at GPCRs: superstition or super agonists?

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 353, doi. 10.1111/bph.12142

By:

Langmead, Christopher J;
Christopoulos, Arthur

Publication type:

Article

Subtype selectivity of α+β− site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 384, doi. 10.1111/bph.12153

By:

Varagic, Zdravko;
Ramerstorfer, Joachim;
Huang, Shengming;
Rallapalli, Sundari;
Sarto‐Jackson, Isabella;
Cook, James;
Sieghart, Werner;
Ernst, Margot

Publication type:

Article

Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 357, doi. 10.1111/bph.12003

By:

Schrage, R;
Seemann, WK;
Klöckner, J;
Dallanoce, C;
Racké, K;
Kostenis, E;
De Amici, M;
Holzgrabe, U;
Mohr, K

Publication type:

Article

The birth of 'regenerative pharmacology': a clinical perspective.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 239, doi. 10.1111/bph.12128

By:

Choudhury, TR;
Mathur, A

Publication type:

Article

Minocycline: far beyond an antibiotic.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 337, doi. 10.1111/bph.12139

By:

Garrido‐Mesa, N;
Zarzuelo, A;
Gálvez, J

Publication type:

Article

Potential for pharmacological manipulation of human embryonic stem cells.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 269, doi. 10.1111/j.1476-5381.2012.01978.x

By:

Atkinson, Stuart P;
Lako, Majlinda;
Armstrong, Lyle

Publication type:

Article

IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B1 and B2 receptors through a STAT6-dependent mechanism.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 400, doi. 10.1111/bph.12116

By:

Souza, PPC;
Brechter, AB;
Reis, RI;
Costa, CAS;
Lundberg, P;
Lerner, UH

Publication type:

Article

Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 290, doi. 10.1111/j.1476-5381.2012.01857.x

By:

Lee, Sangho;
Yoon, Young‐sup

Publication type:

Article

Advantages of an antagonist: bicuculline and other GABA antagonists.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 328, doi. 10.1111/bph.12127

By:

Johnston, Graham AR

Publication type:

Article

Different β-adrenoceptor subtypes coupling to cAMP or NO/ cGMP pathways: implications in the relaxant response of rat conductance and resistance vessels.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 413, doi. 10.1111/bph.12121

By:

Flacco, N;
Segura, V;
Perez‐Aso, M;
Estrada, S;
Seller, JF;
Jiménez‐Altayó, F;
Noguera, MA;
D'Ocon, P;
Vila, E;
Ivorra, MD

Publication type:

Article

Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β− interface.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 371, doi. 10.1111/bph.12151

By:

Varagic, Zdravko;
Wimmer, Laurin;
Schnürch, Michael;
Mihovilovic, Marko D;
Huang, Shengming;
Rallapalli, Sundari;
Cook, James M;
Mirheydari, Pantea;
Ecker, Gerhard F;
Sieghart, Werner;
Ernst, Margot

Publication type:

Article

The macrocyclic tetrapeptide [ D- Trp] CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 426, doi. 10.1111/bph.12132

By:

Eans, Shainnel O;
Ganno, Michelle L;
Reilley, Kate J;
Patkar, Kshitij A;
Senadheera, Sanjeewa N;
Aldrich, Jane V;
McLaughlin, Jay P

Publication type:

Article

Roles of basophils and mast cells infiltrating the lung by multiple antigen challenges in asthmatic responses of mice.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 462, doi. 10.1111/bph.12154

By:

Nabe, T;
Matsuya, K;
Akamizu, K;
Fujita, M;
Nakagawa, T;
Shioe, M;
Kida, H;
Takiguchi, A;
Wakamori, H;
Fujii, M;
Ishihara, K;
Akiba, S;
Mizutani, N;
Yoshino, S;
Chaplin, DD

Publication type:

Article

Ca2+-activated K+ channel ( KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 2, p. 449, doi. 10.1111/bph.12143

By:

González‐Corrochano, R;
La Fuente, JM;
Cuevas, P;
Fernández, A;
Chen, MX;
Sáenz de Tejada, I;
Angulo, J

Publication type:

Article

Works matching IS 00071188 AND DT 2013 AND VI 169 AND IP 2

Sulforaphane protects against ethanol-induced oxidative stress and apoptosis in neural crest cells by the induction of Nrf2-mediated antioxidant response.

Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology.

The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening.

Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.

Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interface.

Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.

Different β-adrenoceptor subtypes coupling to cAMP or NO/cGMP pathways: implications in the relaxant response of rat conductance and resistance vessels.

The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration.

IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B1 and B2 receptors through a STAT6-dependent mechanism.

Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor.

Chemical genetics and its potential in cardiac stem cell therapy.

Issue Information.

Supra-physiological efficacy at GPCRs: superstition or super agonists?

Subtype selectivity of α+β− site ligands of GABA<sub>A</sub> receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.

Agonists with supraphysiological efficacy at the muscarinic M<sub>2</sub> ACh receptor.

The birth of 'regenerative pharmacology': a clinical perspective.

Minocycline: far beyond an antibiotic.

Potential for pharmacological manipulation of human embryonic stem cells.

IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B<sub>1</sub> and B<sub>2</sub> receptors through a STAT6-dependent mechanism.

Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells.

Advantages of an antagonist: bicuculline and other GABA antagonists.

Different β-adrenoceptor subtypes coupling to cAMP or NO/ cGMP pathways: implications in the relaxant response of rat conductance and resistance vessels.

Identification of novel positive allosteric modulators and null modulators at the GABA<sub>A</sub> receptor α+β− interface.

The macrocyclic tetrapeptide [ D- Trp] CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration.

Roles of basophils and mast cells infiltrating the lung by multiple antigen challenges in asthmatic responses of mice.

Ca<sup>2+</sup>-activated K<sup>+</sup> channel ( K<sub>Ca</sub>) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.